跳至主要内容
临床试验/JPRN-UMIN000001120
JPRN-UMIN000001120已完成未知

A randomized trial of lamivudine continuous therapy and entecavir switching therapy for chronic hepatitis B patients treated with lamivudine monotherapy - LVD countinuous therapy vs. ETV switching therapy for CHB patients treated with LVD, randomized trial

agoya City University Hospital0 个研究点目标入组 100 人开始时间: 2008年4月16日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方
入组人数
100

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
20years-old 至 ot applicable(—)
性别
All

入选标准

  • 未提供

排除标准

  • 1) Concomitant medication of nucleoside analogues except for LVD at present. 2) Concomitant medication of IFN. 3) Concomitant medication of immunosuppressant. 4) HBsAb positive patients. 5) Patients with HCC or other malignancy. 6) Patients with decompensated cirrhosis. 7) Pregnant (or possible) women. 8) Patients with under breast feeding. 9) Co-infection with HIV or HCV 10) Other conditions considered inappropriate by attending physician.

研究者

发起方
agoya City University Hospital

相似试验

A randomized trial of lamivudine continuous therapy... | 临床试验